Pan, Hao-Yu
Zhang, Chun-Qian
Zhang, Xiu-Qi
Zeng, Hui
Dong, Chun-hong
Chen, Xia
Ding, Kan
Funding for this research was provided by:
national natural science foundation of china (81903762)
key new drug creation and manufacturing program (2019ZX09735001)
Article History
Received: 17 July 2021
Revised: 2 February 2022
Accepted: 24 February 2022
First Online: 14 March 2022
Declarations
:
: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
: The animal study was reviewed and approved by Animal Ethics Committee of Shanghai Institute of Materia Medica, Chinese Academy of Sciences (No. 2019–02-DK-74), China.